189 related articles for article (PubMed ID: 20484564)
1. Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.
Swanson-Mungerson M; Bultema R; Longnecker R
J Gen Virol; 2010 Sep; 91(Pt 9):2197-202. PubMed ID: 20484564
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.
Swanson-Mungerson MA; Caldwell RG; Bultema R; Longnecker R
J Virol; 2005 Jun; 79(12):7355-62. PubMed ID: 15919890
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T; Longnecker R
Oncogene; 2004 Nov; 23(53):8619-28. PubMed ID: 15361852
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.
Incrocci R; Hussain S; Stone A; Bieging K; Alt LA; Fay MJ; Swanson-Mungerson M
Cell Immunol; 2015 Oct; 297(2):108-19. PubMed ID: 26255694
[TBL] [Abstract][Full Text] [Related]
5. The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function.
Merchant M; Swart R; Katzman RB; Ikeda M; Ikeda A; Longnecker R; Dykstra ML; Pierce SK
Int Rev Immunol; 2001; 20(6):805-35. PubMed ID: 11913951
[TBL] [Abstract][Full Text] [Related]
6. Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A.
Fish K; Comoglio F; Shaffer AL; Ji Y; Pan KT; Scheich S; Oellerich A; Doebele C; Ikeda M; Schaller SJ; Nguyen H; Muppidi J; Wright GW; Urlaub H; Serve H; Staudt LM; Longnecker R; Oellerich T
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26318-26327. PubMed ID: 33020271
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation.
Portis T; Longnecker R
Virology; 2004 Jan; 318(2):524-33. PubMed ID: 14972521
[TBL] [Abstract][Full Text] [Related]
8. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.
Ma SD; Tsai MH; Romero-Masters JC; Ranheim EA; Huebner SM; Bristol JA; Delecluse HJ; Kenney SC
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077657
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro.
Swanson-Mungerson M; Bultema R; Longnecker R
J Virol; 2006 Jul; 80(14):6764-70. PubMed ID: 16809282
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.
Caldwell RG; Wilson JB; Anderson SJ; Longnecker R
Immunity; 1998 Sep; 9(3):405-11. PubMed ID: 9768760
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas.
Incrocci R; McCormack M; Swanson-Mungerson M
J Gen Virol; 2013 May; 94(Pt 5):1127-1133. PubMed ID: 23303827
[TBL] [Abstract][Full Text] [Related]
13. K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.
Steinbrück L; Gustems M; Medele S; Schulz TF; Lutter D; Hammerschmidt W
J Virol; 2015 Jul; 89(14):7248-61. PubMed ID: 25948739
[TBL] [Abstract][Full Text] [Related]
14. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
Guasparri I; Bubman D; Cesarman E
Blood; 2008 Apr; 111(7):3813-20. PubMed ID: 18230756
[TBL] [Abstract][Full Text] [Related]
15. Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.
Konishi K; Maruo S; Kato H; Takada K
J Gen Virol; 2001 Jun; 82(Pt 6):1451-1456. PubMed ID: 11369890
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.
Vrazo AC; Chauchard M; Raab-Traub N; Longnecker R
PLoS Pathog; 2012; 8(4):e1002662. PubMed ID: 22536156
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.
Anderson LJ; Longnecker R
Blood; 2009 Jan; 113(1):108-16. PubMed ID: 18815281
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.
Engels N; Merchant M; Pappu R; Chan AC; Longnecker R; Wienands J
J Exp Med; 2001 Aug; 194(3):255-64. PubMed ID: 11489945
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus: exploiting the immune system.
Thorley-Lawson DA
Nat Rev Immunol; 2001 Oct; 1(1):75-82. PubMed ID: 11905817
[TBL] [Abstract][Full Text] [Related]
20. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
Swart R; Fruehling S; Longnecker R
Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
